Immunome Cash Flow Statement 2018-2024 | IMNM

Fifteen years of historical annual cash flow statements for Immunome (IMNM).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021202020192018
$-106.81$-36.90$-24.71$-17.84$-10.44$-7.85
$0.22$0.63$0.76$0.76$0.62$0.52
$87.03$5.33$2.95$6.16$0.02$0.02
$87.24$5.96$3.71$6.91$0.63$0.54
$0$0$0$0$0$0
$0$0$0$0$0$0
$-0.61$-0.68$1.78$0.50$0.08$0.15
$11.99$4.84$-4.28$-2.41$-0.05$-0.27
$12.00$2.24$2.78$-1.21$0.21$-0.10
$-7.57$-28.69$-18.23$-12.13$-9.60$-7.41
$-0.83$-0.25$-0.08$-0.59$-0.23$-0.23
$0$0$0$0$0$0
$9.28$0$0$0$0$0
$-38.93$0$0$0$0$0
$0$0$0$0$0$0
$-38.93$0$0$0$0$0
$0$0$0$0$0$0
$-30.48$-0.25$-0.08$-0.59$-0.23$-0.23
$0$0$-0.11$0.05$6.19$-0.55
$0$0$0$0$0$0
$0$0$-0.11$0.05$6.19$-0.55
$0.41$0.03$28.66$44.87$0.01$0
$0.41$0.03$28.66$55.87$4.59$0
$0$0$0$0$0$0
$116$0$-0.78$-5.97$0$0
$116$0.03$27.77$49.94$10.77$-0.55
$78.36$-28.91$9.46$37.22$0.94$-8.19
$6.22$5.33$3.45$0.62$0.01$0.01
$0$0$0$0$0$0